BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
  • Homepage
  • Online Submission
Number of total visits
30896480
Number of visits today
850
Number of downloads
13426464
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Singh D, Khan MA, Siddique HR. Role of p53-miRNAs circuitry in immune surveillance and cancer development: A potential avenue for therapeutic intervention. Semin Cell Dev Biol 2021:S1084-9521(21)00076-8. [PMID: 33875349 DOI: 10.1016/j.semcdb.2021.04.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Bizzarri AR, Cannistraro S. Direct Interaction of miRNA and circRNA with the Oncosuppressor p53: An Intriguing Perspective in Cancer Research. Cancers (Basel) 2021;13:6108. [PMID: 34885216 DOI: 10.3390/cancers13236108] [Reference Citation Analysis]
2 Khan MA, Singh D, Ahmad A, Siddique HR. Revisiting inorganic nanoparticles as promising therapeutic agents: A paradigm shift in oncological theranostics. Eur J Pharm Sci 2021;164:105892. [PMID: 34052295 DOI: 10.1016/j.ejps.2021.105892] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Naqvi AR, Sarwat M. MicroRNAs and immunity. Semin Cell Dev Biol 2021:S1084-9521(21)00270-6. [PMID: 34736822 DOI: 10.1016/j.semcdb.2021.10.007] [Reference Citation Analysis]
4 Singh D, Kesharwani P, Alhakamy NA, Siddique HR. Accentuating CircRNA-miRNA-Transcription Factors Axis: A Conundrum in Cancer Research. Front Pharmacol 2021;12:784801. [PMID: 35087404 DOI: 10.3389/fphar.2021.784801] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Singh D, Afsar Khan M, Siddique HR. Specific Targeting of Cancer Stem Cells by Immunotherapy: A Possible Stratagem to Restrain Cancer Recurrence and Metastasis. Biochem Pharmacol 2022;:114955. [PMID: 35181312 DOI: 10.1016/j.bcp.2022.114955] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345